The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy. (Q34469404)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824305%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

review article

1 reference

title

The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824305%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824305%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Rachel Hill

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824305%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

M van den Buuse

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824305%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

31 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824305%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824305%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824305%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824305%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

916-930

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25824305%20AND%20SRC:MED&resulttype=core&format=json

The molecular genetics of cognition: dopamine, COMT and BDNF.

4 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Serotonin transporter gene variants and behavior: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Effects of BDNF polymorphisms on brain function and behavior in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Impact of the BDNF Val66Met polymorphism on cognition: implications for behavioral genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF mRNA splice variants display activity-dependent targeting to distinct hippocampal laminae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Neuronal activity regulates the developmental expression and subcellular localization of cortical BDNF mRNA isoforms in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Spatial segregation of BDNF transcripts enables BDNF to differentially shape distinct dendritic compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Activity-dependent expression of brain-derived neurotrophic factor in dendrites: facts and open questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Mammalian subtilisin/kexin isozyme SKI-1: A widely expressed proprotein convertase with a unique cleavage specificity and cellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Neurotrophins and their receptors: a convergence point for many signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Dendritic trafficking of BDNF mRNA is mediated by translin and blocked by the G196A (Val66Met) mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Identification of SorCS2, a novel member of the VPS10 domain containing receptor family, prominently expressed in the developing mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

SorCS2 regulates dopaminergic wiring and is processed into an apoptotic two-chain receptor in peripheral glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The BDNF Val66Met polymorphism impairs NMDA receptor-dependent synaptic plasticity in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The BDNF Val66Met polymorphism impairs synaptic transmission and plasticity in the infralimbic medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF and activity-dependent synaptic modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Miniature synaptic transmission and BDNF modulate dendritic spine growth and form in rat CA1 neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF release from single cells elicits local dendritic growth in nearby neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF variant Val66Met interacts with estrous cycle in the control of hippocampal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Association between BDNF val66 met genotype and episodic memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurotrophic factor gene on memory-related hippocampal activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

A systematic review and meta-analysis on the association between BDNF val(66)met and hippocampal volume--a genuine effect or a winners curse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF Val66Met and cognition: all, none, or some? A meta-analysis of the genetic association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Impact of the BDNF Val66Met Polymorphism on Regional Brain Gray Matter Volumes: Relevance to the Stress Response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Impact of brain-derived neurotrophic factor Val66Met polymorphism on cortical thickness and voxel-based morphometry in healthy Chinese young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Effect of BDNF val66met polymorphism on age-related amygdala volume changes in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The brain-derived neurotrophic factor Val66Met polymorphism affects memory formation and retrieval of biologically salient stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Genetics of microstructure of cerebral white matter using diffusion tensor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF Val66Met polymorphism influences age differences in microstructure of the Corpus Callosum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

A genetic variant BDNF polymorphism alters extinction learning in both mouse and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF gene effects on brain circuitry replicated in 455 twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Effects of the BDNF Val66Met polymorphism on white matter microstructure in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The brain-derived neurotrophic factor VAL66MET polymorphism and cerebral white matter hyperintensities in late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Evidence of white matter tract disruption in MRI hyperintensities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

To exclude or not to exclude: white matter hyperintensities in diffusion tensor imaging research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The BDNF Val66Met polymorphism and anxiety: support for animal knock-in studies from a genetic association study in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Association of a functional BDNF polymorphism and anxiety-related personality traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The role of genetic variability in the SLC6A4, BDNF and GABRA6 genes in anxiety-related traits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Variation in the BDNF Val66Met polymorphism and response to cognitive-behavior therapy in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The interaction between Comt and Bdnf variants influences obsessive-compulsive-related dysfunctional beliefs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Association study between BDNF gene variants and Mexican patients with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Lack of Association between Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphisms and Generalized Social Anxiety Disorder in Korean Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Association study of a brain-derived neurotrophic factor (Val66Met) genetic polymorphism and panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

No association between the brain-derived neurotrophic factor gene and panic disorder in Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Induction of fear extinction with hippocampal-infralimbic BDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor plays a critical role in contextual fear conditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Fear erasure in mice requires synergy between antidepressant drugs and extinction training.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Impaired fear extinction learning in adult heterozygous BDNF knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The BDNF Val66Met polymorphism modulates the generalization of cued fear responses to a novel context.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The BDNF Val66Met polymorphism affects amygdala activity in response to emotional stimuli: evidence from a genetic imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Effects of the BDNF Val66Met polymorphism on neural responses to facial emotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Candidate-gene approach in posttraumatic stress disorder after urban violence: association analysis of the genes encoding serotonin transporter, dopamine transporter, and BDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The association between brain-derived neurotrophic factor Val66Met variants and psychotic symptoms in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

PTSD risk is associated with BDNF Val66Met and BDNF overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The brain-derived neurotrophic factor Val66Met polymorphism predicts response to exposure therapy in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Association study of candidate variants from brain-derived neurotrophic factor and dystrobrevin-binding protein 1 with neuroticism, anxiety, and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF Val66Met is associated with introversion and interacts with 5-HTTLPR to influence neuroticism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor and neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

A neurotrophic model for stress-related mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Allelic differences in the brain-derived neurotrophic factor Val66Met polymorphism in late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Association study of a brain‐derived neurotrophic‐factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Increase in serum brain-derived neurotrophic factor in met allele carriers of the BDNF Val66Met polymorphism is specific to males

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Depression, the Val66Met polymorphism, age, and gender influence the serum BDNF level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The BDNF Val66Met polymorphism affects HPA-axis reactivity to acute stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Interaction between 5-HTTLPR and BDNF Val66Met polymorphisms on HPA axis reactivity in preschoolers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Interaction between genetic polymorphisms and stressful life events in first episode depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Variant brain-derived neurotrophic factor (Valine66Methionine) polymorphism contributes to developmental and estrous stage-specific expression of anxiety-like behavior in female mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Response to lithium prophylaxis: interaction between serotonin transporter and BDNF genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor (BDNF) gene polymorphisms shape cortical plasticity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF Val66Met genotype and 6-month remission rates in late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Social support in older individuals: the role of the BDNF Val66Met polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Genetic susceptibility to eating disorders: associated polymorphisms and pharmacogenetic suggestions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

A mechanism underlying mature-onset obesity: evidence from the hyperphagic phenotype of brain-derived neurotrophic factor mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF regulates eating behavior and locomotor activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Reversal of Behavioral and Metabolic Abnormalities, and Insulin Resistance Syndrome, by Dietary Restriction in Mice Deficient in Brain-Derived Neurotrophic Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor in the ventromedial nucleus of the hypothalamus reduces energy intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Characteristics of BDNF-induced weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor and obesity in the WAGR syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Association between the brain-derived neurotrophic factor 196G/A polymorphism and eating disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Recapitulation of the association of the Val66Met polymorphism of BDNF gene with BMI in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Family trios analysis of common polymorphisms in the obestatin/ghrelin, BDNF and AGRP genes in patients with Anorexia nervosa: association with subtype, body-mass index, severity and age of onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Modulatory effects of sex steroid hormones on brain-derived neurotrophic factor-tyrosine kinase B expression during adolescent development in C57Bl/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Food restriction leads to binge eating dependent upon the effect of the brain-derived neurotrophic factor Val66Met polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The study of BDNF Val66Met polymorphism in Chinese schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: Evidence from a case-control study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

No evidence for an association between the BDNF Val66Met polymorphism and schizophrenia or personality traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF gene is a risk factor for schizophrenia in a Scottish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The Psychiatric GWAS Consortium: Big Science Comes to Psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The interaction of BDNF and NTRK2 gene increases the susceptibility of paranoid schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Effects of the BDNF val66met polymorphism on prefrontal brain function in a population at high genetic risk of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF val66met genotype and schizotypal personality traits interact to influence probabilistic association learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF Val66Met variant and age of onset in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Age at onset of psychotic disorder: cannabis, BDNF Val66Met, and sex-specific models of gene-environment interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF Val66Met polymorphism and anxiety/depression symptoms in schizophrenia in a Chinese Han population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Childhood abuse, the BDNF-Val66Met polymorphism and adult psychotic-like experiences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Genetic variants in the BDNF gene and therapeutic response to risperidone in schizophrenia patients: a pharmacogenetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naïve patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Effect of the BDNF Val66Met genotype on episodic memory in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor (BDNF) Val(66)Met polymorphism differentially predicts hippocampal function in medication-free patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Recent molecular genetic studies and methodological issues in suicide research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Suicide as an outcome for mental disorders. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Suicide risk in relation to family history of completed suicide and psychiatric disorders: a nested case-control study based on longitudinal registers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Genetics of suicide: a systematic review of twin studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Family genetic studies, suicide, and suicidal behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Low plasma BDNF is associated with suicidal behavior in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF mRNA expression of peripheral blood mononuclear cells was decreased in depressive patients who had or had not recently attempted suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor and suicide pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor Val/Met polymorphism and bipolar disorder. Association of the Met allele with suicidal behavior of bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The BDNF Val66Met polymorphism is an independent risk factor for high lethality in suicide attempts of depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The association between brain-derived neurotrophic factor polymorphism (BDNF Val66Met) and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The brain-derived neurotrophic factor gene in suicidal behaviour: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Association study of BDNF with completed suicide in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Interaction between BDNF Val66Met and childhood trauma on adult's violent suicide attempt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain derived neurotrophic factor (BDNF) genetic polymorphism (Val66Met) in suicide: a study of 512 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Population genetic study of the brain-derived neurotrophic factor (BDNF) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Variant BDNF (Val66Met) impact on brain structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The Val66Met polymorphism of the BDNF gene in anorexia nervosa: new data and a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

New insights into brain BDNF function in normal aging and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Ebbinghaus revisited: influences of the BDNF Val66Met polymorphism on backward serial recall are modulated by human aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Changes in gyrification over 4 years in bipolar disorder and their association with the brain-derived neurotrophic factor valine(66) methionine variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Interaction between BDNF and serotonin: role in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and the early response to antidepressant in Chinese Han population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Mutation screen of the brain derived neurotrophic factor gene (BDNF): Identification of several genetic variants and association studies in patients with obesity, eating disorders, and attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF Val66Met polymorphism is associated with body mass index in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Two British women studies replicated the association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) and BMI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

BDNF Val66Met polymorphism, energy intake and BMI: a follow-up study in schoolchildren at risk of eating disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

No association of brain-derived neurotrophic factor Val66Met polymorphism with anorexia nervosa in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Lack of association between brain-derived neurotrophic factor Val66Met polymorphism and body mass index change over time in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Linkage Disequilibrium of the Brain-Derived Neurotrophic FactorVal66MetPolymorphism in Children With a Prepubertal and Early Adolescent Bipolar Disorder Phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

Polymorphisms in the brain-derived neurotrophic factor gene are not associated with either anorexia nervosa or schizophrenia in Dutch patients

21 January 2018

1 reference

12 December 2020

BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects

1 reference

12 December 2020

Functional variants of the genes involved in neurodevelopment and susceptibility to schizophrenia in an Armenian population

1 reference

12 December 2020

Signaling mechanisms mediating BDNF modulation of synaptic plasticity in the hippocampus.

1 reference

12 December 2020

Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity

1 reference

12 December 2020

Association of the brain-derived neurotrophic factor gene G196A rs6265 polymorphisms and the cognitive function and clinical symptoms of schizophrenia

1 reference

12 December 2020

BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses

1 reference

12 December 2020

[Association between the Val66Met polymorphism of brain-derived neurotrophic factor gene and schizophrenia in Russians]

1 reference

12 December 2020

Positive association between MET allele (BDNF Val66Met polymorphism) and obsessive-compulsive disorder

1 reference

12 December 2020

Enhancement of neurotransmitter release induced by brain-derived neurotrophic factor in cultured hippocampal neurons.

1 reference

12 December 2020

Associations between brain-derived neurotrophic factor G196A gene polymorphism and clinical phenotypes in schizophrenia patients

1 reference

12 December 2020

Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder

1 reference

12 December 2020

No association of the brain-derived neurotrophic factor (BDNF) gene polymorphisms with panic disorder

1 reference

12 December 2020

1 reference

12 December 2020

Alterations in nigrostriatal dopaminergic function within BDNF mutant mice

1 reference

12 December 2020

Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations

1 reference

12 December 2020

11p14.1 microdeletions associated with ADHD, autism, developmental delay, and obesity

1 reference

12 December 2020

Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance.

1 reference

12 December 2020

Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication

1 reference

12 December 2020

Brain derived neurotrophic factor gene Val66Met and -270C/T polymorphisms and personality traits predisposing to anorexia nervosa.

1 reference

12 December 2020

Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects.

1 reference

12 December 2020

BDNF genetic variations increase the risk of Alzheimer's disease-related depression

1 reference

12 December 2020

Exploring the gene-environment nexus in eating disorders.

1 reference

12 December 2020

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.

1 reference

12 December 2020

[Association between polymorphisms of Val66Met in the BDNF gene and the response to escitalopram and nortriptyline treatment in the light of the neurodevelopmental hypothesis of depression].

1 reference

12 December 2020

Synapsins as mediators of BDNF-enhanced neurotransmitter release

1 reference

12 December 2020

No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and post-traumatic stress disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

7 January 2021

inferred from DOI database lookup

Association of the Val66Met polymorphism of the brain-derived neurotrophic factor gene with schizophrenia in Russians

1 reference

https://api.crossref.org/works/10.1038%2FMP.2015.27

7 January 2021